Galecto Inc (GLTO)
0.6051
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.6051
0.00 (0.00%)
After-Hours: 20:00
Galecto Price to Book Value: 0.5826 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.5826 |
| May 30, 2024 | 0.5873 |
| May 29, 2024 | 0.5825 |
| May 28, 2024 | 0.60 |
| May 24, 2024 | 0.6065 |
| May 23, 2024 | 0.6015 |
| May 22, 2024 | 0.5946 |
| May 21, 2024 | 0.5903 |
| May 20, 2024 | 0.6123 |
| May 17, 2024 | 0.598 |
| May 16, 2024 | 0.6066 |
| May 15, 2024 | 0.6087 |
| May 14, 2024 | 0.6547 |
| May 13, 2024 | 0.6548 |
| May 10, 2024 | 0.6545 |
| May 09, 2024 | 0.6741 |
| May 08, 2024 | 0.6788 |
| May 07, 2024 | 0.6837 |
| May 06, 2024 | 0.6837 |
| May 03, 2024 | 0.6741 |
| May 02, 2024 | 0.6904 |
| May 01, 2024 | 0.6548 |
| April 30, 2024 | 0.6504 |
| April 29, 2024 | 0.6756 |
| April 26, 2024 | 0.6786 |
| Date | Value |
|---|---|
| April 25, 2024 | 0.644 |
| April 24, 2024 | 0.6461 |
| April 23, 2024 | 0.6746 |
| April 22, 2024 | 0.6557 |
| April 19, 2024 | 0.6562 |
| April 18, 2024 | 0.6932 |
| April 17, 2024 | 0.6493 |
| April 16, 2024 | 0.6618 |
| April 15, 2024 | 0.6618 |
| April 12, 2024 | 0.6557 |
| April 11, 2024 | 0.6741 |
| April 10, 2024 | 0.6547 |
| April 09, 2024 | 0.6879 |
| April 08, 2024 | 0.6848 |
| April 05, 2024 | 0.7318 |
| April 04, 2024 | 0.7029 |
| April 03, 2024 | 0.7051 |
| April 02, 2024 | 0.7366 |
| April 01, 2024 | 0.7172 |
| March 28, 2024 | 0.6541 |
| March 27, 2024 | 0.6541 |
| March 26, 2024 | 0.6327 |
| March 25, 2024 | 0.622 |
| March 22, 2024 | 0.6574 |
| March 21, 2024 | 0.6424 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3042
Minimum
May 24 2022
2.023
Maximum
Jan 12 2021
0.7692
Average
0.6607
Median
Oct 06 2021
Price to Book Value Benchmarks
| Novo Nordisk A/S | 42.12 |
| Genmab A/S | 3.868 |
| Ascendis Pharma A/S | -- |
| Evaxion Biotech AS | 3.589 |
| IO Biotech Inc | 0.6761 |
Price to Book Value Related Metrics
| Price | 0.6051 |
| Earnings Yield | -188.4% |
| Market Cap | 16.41M |